Sign In
Buy DVA
$183.69
-0.0800 (-0.0435%)
At Close: Aug 10, 2026
Is DaVita (DVA) a Great Value Stock Right Now?
10:41am, Thursday, 06'th Aug 2026
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
DaVita Stock Down in Pre-Market Despite Q2 Earnings Beat, Margins Down
03:46pm, Wednesday, 05'th Aug 2026
DVA's second-quarter 2026 results show profit growth, but narrowing margins and a weaker commercial mix weigh on the performance.
Dow Extends Record Run With Over 400-Point Pop
12:19pm, Wednesday, 05'th Aug 2026
The Dow is up triple digits and trading at record highs as upbeat corporate earnings continue to roll in and lift Wall Street
DVA Q2 Earnings Call Centers on Clinical-Led Volume Growth
11:01am, Wednesday, 05'th Aug 2026
DaVita's Q2 earnings call highlights mortality-led volume gains and broader middle molecule access, while management held 2026 guidance amid reimbursement pressure.
DaVita Q2 Earnings Call Highlights
02:04am, Wednesday, 05'th Aug 2026
DaVita NYSE: DVA reported second-quarter results that management said were broadly in line with expectations, supported by accelerating treatment-volume growth and lower mortality among patients. The
DaVita Inc (DVA) (Q2 2026) Earnings Call Highlights: Strong Volume Growth and Strategic Execution Drive Confidence
12:03am, Wednesday, 05'th Aug 2026
Adjusted Operating Income: $579 million in Q2 2026.Adjusted Earnings Per Share: $4.02 in Q2 2026.Free Cash Flow: $256 million in Q2 2026.U.S. Dialysis Treatment
DaVita Inc. (DVA) Q2 2026 Earnings Call Transcript
09:10pm, Tuesday, 04'th Aug 2026
DaVita Inc. (DVA) Q2 2026 Earnings Call Transcript
DaVita flags lower revenue per treatment, reaffirms annual forecast
06:45pm, Tuesday, 04'th Aug 2026
DaVita said on Tuesday revenue per treatment was lower in the second quarter, blaming declining enrollments for dialysis treatments as patients dropped out of Obamacare plans following the end o
DaVita HealthCare (DVA) Q2 Earnings and Revenues Top Estimates
06:41pm, Tuesday, 04'th Aug 2026
DaVita HealthCare (DVA) came out with quarterly earnings of $4.02 per share, beating the Zacks Consensus Estimate of $4.01 per share. This compares to earnings of $2.95 per share a year ago.
Is DaVita Inc (DVA) Overvalued After Q2 Earnings Beat? EPS at $4.02 and Revenue at $3.554 Billion; GF Score: 86/100
04:31pm, Tuesday, 04'th Aug 2026
On August 4, 2026, DaVita Inc (DVA) released its 8-K filing, revealing financial and operational results for the quarter ended June 30, 2026. As one of the larg
DaVita Inc. 2nd Quarter 2026 Results
04:05pm, Tuesday, 04'th Aug 2026
DENVER, Aug. 4, 2026 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended June 30, 2026. "Thanks to the outstanding efforts of our teammates, we had
Can Volume Growth and RPT Recovery Support DaVita's Q2 Earnings?
01:51pm, Monday, 03'rd Aug 2026
DVA's Q2 results are likely to benefit from volume growth and RPT recovery, but payor mix pressure and spending on technology could limit margin gains.
Here's Why You Should Retain DaVita Stock in Your Portfolio for Now
12:07pm, Wednesday, 29'th Jul 2026
DVA's IKC momentum, higher 2026 guidance and technology investments support growth, while reimbursement and payer-mix risks cloud the outlook.
Why DaVita HealthCare (DVA) Outpaced the Stock Market Today
07:01pm, Tuesday, 28'th Jul 2026
In the latest trading session, DaVita HealthCare (DVA) closed at $239.46, marking a +1.33% move from the previous day.
DaVita Inc. Schedules 2nd Quarter 2026 Investor Conference Call
05:00pm, Tuesday, 21'st Jul 2026
DENVER, July 21, 2026 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Tuesday, August 4, 2026, at 5:00
